Skip to main content

Peer Review reports

From: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines

Original Submission
18 Dec 2019 Submitted Original manuscript
17 Apr 2020 Author responded Author comments - Karolin Ebert
11 Feb 2020 Reviewed Reviewer Report
18 Feb 2020 Reviewed Reviewer Report - Raquel Chaves
Resubmission - Version 2
17 Apr 2020 Submitted Manuscript version 2
21 Jul 2020 Author responded Author comments - Karolin Ebert
12 Jun 2020 Reviewed Reviewer Report
22 Jun 2020 Reviewed Reviewer Report
Resubmission - Version 3
21 Jul 2020 Submitted Manuscript version 3
3 Sep 2020 Author responded Author comments - Karolin Ebert
14 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 4
3 Sep 2020 Submitted Manuscript version 4
9 Oct 2020 Author responded Author comments - Karolin Ebert
Resubmission - Version 5
9 Oct 2020 Submitted Manuscript version 5
Publishing
18 Oct 2020 Editorially accepted
28 Oct 2020 Article published 10.1186/s12885-020-07540-7

You can find further information about peer review here.

Back to article page
\